Skip to main content
Clinical Trials/CTRI/2015/04/005707
CTRI/2015/04/005707
Completed
Phase 3

A randomized multicenter Clinical Study to evaluate efficacy and safety of Zandu Junior balm and market preparation in relieving symptoms in Children - NI

Emami Limited0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Emami Limited
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Willing to provide informed consent to participate in the study
  • Males or females Child 04\-12 years of age both inclusive.
  • Diagnosis of Mild to Moderate Headache, Body ache and other symptoms of cough cold.

Exclusion Criteria

  • Subjects having persistent headache, body ache or other symptoms which in the opinion of the investigator require proper medical diagnosis and management
  • Subjects who have associated moderate to high fever and those who require rescue medicines like analgesics
  • Immuno compromised children
  • Children allergic to application of products similar to test product.

Outcomes

Primary Outcomes

Not specified

Similar Trials